Pharmaceuticals and Healthcare Report in Global
Company Report
Summary
B&C Biopharm (B&C) is a biopharmaceutical venture company. The company discovers and develops pharmaceutical products for the treatment of the infectious diseases. B&C’s product portfolio includes NS5B inhibitors, BC2125, BC2329, NS3 inhibitors, PPI inhibitors, and antifungal agents. The company conducts research to develop therapeutics for Hepatitis C, NS5B RNA polymerase, and NS3 helicase, among others. Its Korean’s patents for drug discoveries are 446669, 516434, and 516433 among ...
Download Sample
Preview Sample